Tag: BioNTech
-
BioNTech to develop mRNA-based single shots
Germany’s BioNTech and US pharma expert Pfizer, which together fostered a COVID-19 antibody in record time, said Wednesday they are chipping away at a shingles shot utilizing a similar mRNA innovation. Moderna in the mean time reported it had dosed its first volunteer for an immunization against Epstein-Barr infection (EBV), the reason for mononucleosis. The…
-
Pfizer vaccine soon to be administered to kids aged between 12 and 15
Lahore, 21st April: Pfizer has requested to expand the use of its coronavirus vaccine to kids aged between 12 and 15. Pfizer has requested the Food and Drug Administration (FDA) to authorize its emergency use which the FDA had originally granted during the end of the year 2020 for people ages 16 and up. Pfizer-BioNtech told…
-
Hungary starts using Chinese vaccine in EU first
Hungary on Wednesday became the first EU nation to start using China’s coronavirus Sinopharm vaccine
-
BioNTech says ‘committed’ to supplying Taiwan with vaccine
Germany’s BioNTech said it still intends to provide Taiwan with coronavirus vaccine doses
-
Lebanon Receives First COVID Vaccines
Lebanon has received its first COVID vaccines.
-
Virus Jabs for All Regardless of Immigration Status, Says UK
UK says that everyone will get virus jabs, regardless of immigration status.
-
Virus jabs for all regardless of immigration status, says UK
London, Feb 8 (AFP/APP):Undocumented migrants in Britain will still be able to get Covid vaccines without being subject to status checks, the government said on Monday. Anyone in Britain can register with doctors and access free frontline medical care, regardless of their immigration status. Some data is shared with the interior ministry, which is responsible…
-
EU Keeping Details of Corona Vaccine Confidential
Brussels, Jan 7 (AFP/APP): The European Union will keep the details of its contracts with Covid-19 vaccine makers secret while negotiating with them, the bloc’s commissioner for health said Thursday. “We are bound by the confidentiality clauses of the contract, and disclosure of any confidential information at this moment in time undermines the ongoing negotiations…
-
BioNTech Fills the Gap of Approved Vaccines
Frankfurt Main, Jan 1 (AFP/APP): German firm BioNTech said Friday it was racing to ramp up production of its Covid-19 jab in Europe, to fill the “gap” left by the lack of other approved vaccines. The vaccine developed by BioNTech and its US partner Pfizer was the first to be approved in the European Union…
-
COVID-19: BioNTech to make the vaccine for the new variant
London, 22nd December: BioNTech has said that it can make a vaccine for the new variant of coronavirus detected in the UK within six weeks. According to reports, the co-founder of BioNTech said on Tuesday it was highly likely that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it…